Henan Lingrui Pharmaceutial Co., Ltd. Class ASSE: 600285

Announcement on Convening Performance Briefing for 2025 and Q1 2026

· Issued by Henan Lingrui Pharmaceutial Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Convening Performance Briefing for 2025 and Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Henan Lingrui Pharmaceutial Co., Ltd. Class A

All Henan Lingrui Pharmaceutial Co., Ltd. Class A news releases